Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · IEX Real-Time Price · USD
4.500
+0.350 (8.43%)
Jul 19, 2024, 4:00 PM EDT - Market closed

Kiora Pharmaceuticals Statistics

Total Valuation

KPRX has a market cap or net worth of $13.37 million. The enterprise value is -$17.82 million.

Market Cap 13.37M
Enterprise Value -17.82M

Important Dates

The next estimated earnings date is Tuesday, August 6, 2024, before market open.

Earnings Date Aug 6, 2024
Ex-Dividend Date n/a

Share Statistics

KPRX has 2.97 million shares outstanding. The number of shares has increased by 1,779.59% in one year.

Shares Outstanding 2.97M
Shares Change (YoY) +1,779.59%
Shares Change (QoQ) +623.36%
Owned by Insiders (%) 2.03%
Owned by Institutions (%) 49.25%
Float 1.45M

Valuation Ratios

PE Ratio n/a
Forward PE 2.13
PS Ratio 0.84
Forward PS n/a
PB Ratio 0.38
P/FCF Ratio 1.87
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 21.02, with a Debt / Equity ratio of 0.00.

Current Ratio 21.02
Quick Ratio 19.76
Debt / Equity 0.00
Debt / EBITDA 0.03
Debt / FCF 0.01
Interest Coverage 261.35

Financial Efficiency

Return on equity (ROE) is 14.50% and return on invested capital (ROIC) is 11.97%.

Return on Equity (ROE) 14.50%
Return on Assets (ROA) 9.90%
Return on Capital (ROIC) 11.97%
Revenue Per Employee $1.33M
Profits Per Employee $189,739
Employee Count 12
Asset Turnover 0.70
Inventory Turnover n/a

Taxes

In the past 12 months, KPRX has paid $90,319 in taxes.

Income Tax 90,319
Effective Tax Rate 3.82%

Stock Price Statistics

The stock price has decreased by -21.88% in the last 52 weeks. The beta is -0.23, so KPRX's price volatility has been lower than the market average.

Beta (5Y) -0.23
52-Week Price Change -21.88%
50-Day Moving Average 4.46
200-Day Moving Average 5.09
Relative Strength Index (RSI) 53.21
Average Volume (20 Days) 35,217

Short Selling Information

The latest short interest is 40,422, so 1.36% of the outstanding shares have been sold short.

Short Interest 40,422
Short Previous Month 36,216
Short % of Shares Out 1.36%
Short % of Float 2.79%
Short Ratio (days to cover) 0.77

Income Statement

In the last 12 months, KPRX had revenue of $16.00 million and earned $2.28 million in profits.

Revenue 16.00M
Gross Profit 16.00M
Operating Income 4.32M
Pretax Income 2.90M
Net Income 2.28M
EBITDA 2.95M
EBIT 2.91M
Earnings Per Share (EPS) -$11.34
Full Income Statement

Balance Sheet

The company has $31.28 million in cash and $94,299 in debt, giving a net cash position of $31.19 million or $10.50 per share.

Cash & Cash Equivalents 31.28M
Total Debt 94,299
Net Cash 31.19M
Net Cash Per Share $10.50
Equity (Book Value) 34.90M
Book Value Per Share 11.75
Working Capital 31.89M
Full Balance Sheet

Cash Flow

Operating Cash Flow 7.14M
Capital Expenditures n/a
Free Cash Flow 7.14M
FCF Per Share $2.48
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 27.02% and 14.23%.

Gross Margin 100.00%
Operating Margin 27.02%
Pretax Margin 18.11%
Profit Margin 14.23%
EBITDA Margin 18.41%
EBIT Margin 18.18%
FCF Margin 44.61%

Dividends & Yields

KPRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1,779.59%
Shareholder Yield -1,779.59%
Earnings Yield 17.03%
FCF Yield 53.39%

Analyst Forecast

The average price target for KPRX is $18.00, which is 300.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target $18.00
Price Target Difference 300.00%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -56.73%
Stock Forecasts

Stock Splits

The last stock split was on June 11, 2024. It was a reverse split with a ratio of 1:9.

Last Split Date Jun 11, 2024
Split Type Reverse
Split Ratio 1:9

Scores

KPRX has an Altman Z-Score of -1.84 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.84
Piotroski F-Score 5